Boothbay Fund Management »

Galectin Therapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Galectin Therapeutics

20162017201820192020202120222023202420250200k400k600k800k0100k200k300k
Value ($)Share countHistorical GALT position of Boothbay Fund Management Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $804k 292k 2.75
2021-06-30 $35k 11k 3.19
2019-03-31 $78k 15k 5.09
2018-12-31 $105k 31k 3.44
2016-06-30 $28k 19k 1.49
2016-03-31 $27k 19k 1.43
2015-12-31 $21k 13k 1.66